These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma. Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y. Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784 [Abstract] [Full Text] [Related]
30. Clinicopathologic significance of HMGA2 expression's correlation with prognosis of esophageal squamous cell carcinoma after Ivor Lewis esophagectomy. Zhang M, Hu D, Wang S, Qin C. Minerva Chir; 2016 Aug; 71(4):239-44. PubMed ID: 27119517 [Abstract] [Full Text] [Related]
34. The prognostic significance of the positive circumferential resection margin in pathologic T3 squamous cell carcinoma of the esophagus with or without neoadjuvant chemotherapy. Okada N, Fujii S, Fujita T, Kanamori J, Kojima T, Hayashi R, Daiko H. Surgery; 2016 Feb; 159(2):441-50. PubMed ID: 26391150 [Abstract] [Full Text] [Related]
35. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma]. Chen H, He J. Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):294-7. PubMed ID: 24989917 [Abstract] [Full Text] [Related]
37. The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma. Han L, Song Q, Jia Y, Chen X, Wang C, Chen P, Min R, Cheng Y. Tumour Biol; 2016 Mar; 37(3):3081-90. PubMed ID: 26423404 [Abstract] [Full Text] [Related]
38. Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients. Ma MQ, Yu ZT, Tang P, Jiang HJ, Zhao XJ, Zhang JG, Qu DW, Jin QW, Zhang XZ. Int J Clin Exp Pathol; 2015 Mar; 8(5):5008-16. PubMed ID: 26191194 [Abstract] [Full Text] [Related]
39. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. Wang L, Wang C, Wang J, Huang X, Cheng Y. J Cancer Res Clin Oncol; 2017 Oct; 143(10):2077-2086. PubMed ID: 28601935 [Abstract] [Full Text] [Related]
40. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Xu F, Xu CZ, Gu J, Liu X, Liu R, Huang E, Yuan Y, Zhao G, Jiang J, Xu C, Chu Y, Lu C, Ge D. Oncotarget; 2016 Jul 12; 7(28):43401-43411. PubMed ID: 27270324 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]